Lannett Co Inc (LCI): Price and Financial Metrics
Lannett Co Inc (LCI)
Today's Latest Price: $7.01 USD
Updated Oct 23 7:00pm
Add LCI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
LCI Stock Summary
- The price/operating cash flow metric for Lannett Co Inc is higher than only 14.77% of stocks in our set with a positive cash flow.
- Over the past twelve months, LCI has reported earnings growth of -106.96%, putting it ahead of only 17.34% of US stocks in our set.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for LCI comes in at 23.03% -- higher than that of 89.31% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Lannett Co Inc are HL, FCEL, SPR, ENVA, and CETX.
- LCI's SEC filings can be seen here. And to visit Lannett Co Inc's official web site, go to www.lannett.com.
LCI Stock Price Chart Interactive Chart >
LCI Price/Volume Stats
| Current price | $7.01 | 52-week high | $13.12 |
| Prev. close | $7.04 | 52-week low | $4.89 |
| Day low | $6.90 | Volume | 173,668 |
| Day high | $7.08 | Avg. volume | 636,632 |
| 50-day MA | $6.11 | Dividend yield | N/A |
| 200-day MA | $7.27 | Market Cap | 281.95M |
Lannett Co Inc (LCI) Company Bio
Lannett Company develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.
LCI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $7.01 | $10.67 | 52% |
We started the process of determining a valid price forecast for Lannett Co Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Lannett Co Inc ranked in the 56th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 53%. The most interesting components of our discounted cash flow analysis for Lannett Co Inc ended up being:
- The company's debt burden, as measured by earnings divided by interest payments, is 0.27 -- which is good for besting only 24.78% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
- 28% of the company's capital comes from equity, which is greater than merely 11.93% of stocks in our cash flow based forecasting set.
- Lannett Co Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 49% |
| 1% | 51% |
| 2% | 52% |
| 3% | 54% |
| 4% | 55% |
| 5% | 57% |
Want more companies with a valuation profile/forecast similar to that of Lannett Co Inc? See UNH, ACIU, REGN, EGRX, and UTHR.
Loading social stream, please wait...